Upregulation of both ERBB1/EGFR and ERBB2/HER2 is observed in progression from BE to EAC and increased surface expression has been used for in vivo detection using fluorescent peptides targeting these two proteins [86,87,88,89,90]. This evidence concerns the gene EGFR and Barrett esophagus.